Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation

International Journal of Pharmaceutics

Volumn 420, Issue 1, 2011, Pages 133-140

  Al Shaal, Loaye ^a   Shegokar, Ranjita ^a   Müller, Rainer H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Antioxidant activity; Apigenin; DPPH assay; smartCrystals

Indexed keywords

APIGENIN; NANOCRYSTAL;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG FORMULATION; DRUG SOLUBILITY; PARTICLE SIZE; PRIORITY JOURNAL; SKIN PROTECTION; SUSPENSION;

ADMINISTRATION, CUTANEOUS; ANTIOXIDANTS; APIGENIN; BIPHENYL COMPOUNDS; CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY, X-RAY; HUMANS; KINETICS; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; PERMEABILITY; PICRATES; SKIN; SOLUBILITY; SUNBURN; SUNSCREENING AGENTS; TECHNOLOGY, PHARMACEUTICAL; ULTRAVIOLET RAYS;

EID: 80054679610     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.08.018     Document Type: Article

References (51)

1. L. Al Shaal, R.H. Müller, and R. Shegokar smartCrystal combination technology - scale up from lab to pilot scale and long term stability Pharmazie 65 2010 877 884
2. M. Antolovich, P.D. Prenzler, E. Patsalides, S. McDonald, and K. Robards Methods for testing antioxidant activity Analyst 127 2002 183 198 (Pubitemid 34081656)
3. I. Bala, V. Bhardwaj, S. Hariharan, J. Sitterberg, U. Bakowsky, and M.N.V.R. Kumar Design of biodegradable nanoparticles: a novel approach to encapsulating poorly soluble phytochemical ellagic acid Nanotechnology 16 2005 2819 2822 (Pubitemid 41677035)
4. W. Brandwilliams, M.E. Cuvelier, and C. Berset Use of a free-radical method to evaluate antioxidant activity Food Sci. Technol. - LWT 28 1995 25 30
5. G. Buckton, and A.E. Beezer The relationship between particle size and solubility Int. J. Pharm. 82 1992 R7 R10
6. D. Fasolo, V.L. Bassani, and H.F. Teixeira Development of topical nanoemulsions containing quercetin and 3-O-methylquercetin Pharmazie 64 2009 726 730
7. J. Gabrielska, J. Oszmianski, R. Zylka, and M. Komorowska Antioxidant activity of flavones from Scutellaria baicalensis in lecithin liposomes Z. Naturforsch. C - J. Biosci. 52 1997 817 823 (Pubitemid 28091354)
8. M. Goniotaki, S. Hatziantoniou, K. Dimas, M. Wagner, and C. Demetzos Encapsulation of naturally occurring flavonoids into liposomes: physicochemical properties and biological activity against human cancer cell lines J. Pharm. Pharmacol. 56 2004 1217 1224 (Pubitemid 39368991)
9. E. Graf Antioxidant potential of ferulic acid Free Radic. Biol. Med. 13 1992 435 448
10. D. Harman Free radical theory of aging: an update: increasing the functional life span Ann. N. Y. Acad. Sci. 1067 2006 10 21 (Pubitemid 43806304)
11. B.H. Havsteen The biochemistry and medical significance of the flavonoids Pharmacol. Therapeut. 96 2002 67 202 (Pubitemid 35356564)
12. J. Hecq, M. Deleers, D. Fanara, H. Vranckx, and K. Amighi Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine Int. J. Pharm. 299 2005 167 177 (Pubitemid 40962418)
13. B. Holst, and G. Williamson Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants Curr. Opin. Biotechnol. 19 2008 73 82
14. J. Jinno, N. Kamada, M. Miyake, K. Yamada, T. Mukai, M. Odomi, H. Toguchi, G.G. Liversidge, K. Higaki, and T. Kimura Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs J. Control. Release 111 2006 56 64 (Pubitemid 43289995)
15. C.M. Keck NanoCrystal® Technology: a formulation approach for poorly water soluble compounds I.L. Sciences, Particle Design for APIs and Drug Products 8-10th September, Brussels 2008
16. C.M. Keck, S. Kobierski, R. Mauludin, and R.H. Müller Second generation of drug nanocrystals for delivery of poorly soluble drugs: smartCrystals technology Dosis 2 2008 124 128
17. J. Kerč, S. Kobierski, C.M. Keck, and R.H. Müller Influence of different stabilizers on particle size of apigenin nanosuspensions produced by high pressure homogenization International Symposium on Controlled Release of Bioactive Materials vol. 36 2009 Controlled Release Society, Inc. Copenhagen p. 3885
18. D.J. Kim, H.D. Jang, E.J. Kim, and K.K. Koo Effect of reaction temperatures and media on crystal structure of colloidal nanocrystals synthesized from an aerosol flow system Ultramicroscopy 108 2008 1278 1282
19. J.E. Kipp, J.C.T. Wong, M.J. Doty, and C.L. Rebbeck Microprecipitation method for preparing submicron suspensions United States Patent 6,607,784 2003 Baxter International Inc. Deerfield, IL, USA
20. S. Kobierski, L. Al Shaal, C.M. Keck, J. Kerč, and R.H. Müller Preparation and physical evaluation of ascorbyl palmitate nanosuspensions AAPS Annual Meeting Atlanta, USA 2008
21. S. Kobierski, R. Mauludin, C.M. Keck, and R.H. Müller Production of Hesperidin dermal nanocrystals by novel smartCrystal combination technology European Workshop on Particulate Systems 30-31th May, Berlin 2008
22. S. Kobierski, K. Ofori-Kwakye, R.H. Muller, and C.M. Keck Resveratrol nanosuspensions for dermal application - production, characterization, and physical stability Pharmazie 64 2009 741 747
23. R. Kohen, and A. Nyska Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification Toxicol. Pathol. 30 2002 620 650 (Pubitemid 36018731)
24. G. Liversidge Workshop Nanotechnology - solid particles, lipids and nanocomplexes IIR Drug Delivery Partnerships™ Meeting Cologne, Germany 2003
25. H. Masaki Role of antioxidants in the skin: anti-aging effects J. Dermatol. Sci. 58 2010 85 90
26. R. Mauludin, R.H. Müller, and C.M. Keck Development of an oral rutin nanocrystal formulation Int. J. Pharm. 370 2009 202 209
27. P.R. Mishra, L. Al Shaal, R.H. Müller, and C.M. Keck Production and characterization of Hesperetin nanosuspensions for dermal delivery Int. J. Pharm. 371 2009 182 189
28. L. Montenegro, F. Bonina, L. Rigano, S. Giogilli, and S. Sirigu Protective effect evaluation of free radical scavengers on UVB induced human cutaneous erythema by skin reflectance spectrophotometry Int. J. Cosmetic Sci. 17 1995 91 103
29. J. Möschwitzer, and A. Lemke Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof W.I. Property, PCT/EP2006/003377 2007 ABBOTT GmbH & CO.KG Germany
30. R.H. Müller, J. Hanisch, R. Mauludin, R. Petersen, and C.M. Keck Rutin drug nanocrystals for dermal cosmetic application AAPS Annual Meeting 2007
31. R.H. Müller, and S. Heinemann Emulsions for Intravenous Application. II. Destabilisation and stabilisation mechanisms in fat emulsions Die Pharm. Ind. 55 1993 948 953 (Pubitemid 23329214)
32. R.H. Müller, and C. Jacobs Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability Int. J. Pharm. 237 2002 151 161 (Pubitemid 34310488)
33. R.H. Müller, C. Jacobs, and O. Kayser Nanosuspensions for the formulation of poorly soluble drugs F. Nielloud, G. Marti-Mestres, Pharmaceutical Emulsions and Suspensions 2000 Marcel Dekker 383 407
34. R.H. Müller, C.M. Keck, and R.D. Petersen Rutin smartCrystals: bioactivity enhancement and stability against electrolytes Annual Meeting of the American Association of Pharmaceutical Scientists (AAPS) Atlanta, USA 2008
35. R.H. Müller, and J. Möschwitzer Method and device for producing very fine particles and coating such particles W.I. Property, PCT/EP2006/009930 2007 ABBOTT GmbH & CO. KG Germany
36. A.A. Naumov, Y.V. Shatalin, and M.M. Potselueva Effects of a nanocomplex containing antioxidant lipid, and amino acid on thermal burn wound surface Bull. Exp. Biol. Med. 149 2010 62 66
37. M. Ndiaye, R. Kumar, and N. Ahmad Resveratrol in cancer management: where are we and where we go from here? Resveratrol Health 1215 2011 144 149
38. C. Nyström Dissolution properties of soluble drugs: theoretical background and possibilities to improve the dissolution behavior R.H. Müller, S. Benita, B. Böhm, Medpharm Scientific 1998 Stuttgart 143 147
39. J. Patela, R. Patelb, K. Khambholjab, and N. Patela An overview of phytosomes as an advanced herbal drug delivery system Asian J. Pharm. Sci. 4 2009 363 371
40. Petersen, R., 2006a. Nanocrystals for use in topical cosmetic formulations and method of production thereof. US Patent 60/8866233.
41. R.D. Petersen Nanocrystals for use in topical formulations and method of production thereof PCT/EP2007/009943 2006 Abbott GmbH, Petersen, R.D Germany
42. M. Portugal, V. Barak, I. Ginsburg, and R. Kohen Interplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerations Biomed. Pharmacother. 61 2007 412 422 (Pubitemid 47239346)
43. T.M. Riddick Control of colloid stability through zeta potential; with a closing chapter on its relationship to cardiovascular disease 1968 Zeta-Meter, Inc Wynnewood, PA
44. M.M. Rieger, and M. Pains Oxidative reactions in and on the skin: mechanism and prevention Cosmetic Toiletries 108 1993 43 56
45. L. Rittie, and G.J. Fisher UV-light-induced signal cascades and skin aging Ageing Res. Rev. 1 2002 705 720 (Pubitemid 38344146)
46. K.U. Schabeuter, and J.M. Wood Free radicals in the human epidermis Free Radic. Biol. Med. 6 1989 519 532
47. F. Shahidi, and M. Naczk Food phenolics: an overview F. Shahidi, M. Naczk, Food Phenolics: Sources, Chemistry, Effects, Applications 1995 Echnomic Publishing Company Inc Lancaster 1 5
48. R. Shegokar, and R.H. Müller Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives Int. J. Pharm. 399 2010 129 139
49. D.E. Stevenson, and R.D. Hurst Polyphenolic phytochemicals - just antioxidants or much more? Cell. Mol. Life Sci. 64 2007 2900 2916 (Pubitemid 351152245)
50. L. Willems, R. van der Geest, and K. de Beule Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics J. Clin. Pharm. Ther. 26 2001 159 169 (Pubitemid 32592545)
51. S.A. Wissing, and R.H. Müller The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles Int. J. Pharm. 242 2002 373 375